SHSAX Holdings Information

SHSAX is a mutual fund with a total of 168 individual holdings. The top holdings are Eli Lilly and Company stock at 10.87%, Johnson & Johnson at 9.52%, AbbVie at 4.02%, Gilead Sciences at 3.84%, and UnitedHealth Group at 3.22%.

Total Holdings

168

Top 10 Percentage

46.09%

Asset Class

Equity

Fund Category

Health

Assets

6.53B

Forward PE Ratio

20.65

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.87%	677,687
2	JNJ	Johnson & Johnson	9.52%	2,708,472
3	ABBV	AbbVie Inc.	4.02%	1,166,372
4	GILD	Gilead Sciences, Inc.	3.84%	1,749,430
5	UNH	UnitedHealth Group Incorporated	3.22%	725,814
6	AMGN	Amgen Inc.	3.13%	592,564
7	MRK	Merck & Co., Inc.	3.03%	1,778,571
8	TMO	Thermo Fisher Scientific Inc.	3.00%	335,753
9	MDT	Medtronic plc	2.94%	1,844,322
10	ISRG	Intuitive Surgical, Inc.	2.51%	321,441
11	DHR	Danaher Corporation	2.44%	721,557
12	ABT	Abbott Laboratories	2.32%	1,372,096
13	EW	Edwards Lifesciences Corporation	2.17%	1,723,792
14	VRTX	Vertex Pharmaceuticals Incorporated	2.00%	275,365
15	SYK	Stryker Corporation	1.92%	335,566
16	BSX	Boston Scientific Corporation	1.87%	1,293,983
17	ARGX	argenx SE	1.59%	122,249
18	TEVA	Teva Pharmaceutical Industries Limited	1.46%	2,765,040
19	COR	Cencora, Inc.	1.32%	236,970
20	LON: AZN	AstraZeneca PLC	1.31%	453,141
21	ALNY	Alnylam Pharmaceuticals, Inc.	1.09%	208,701
22	SWX: ROG	Roche Holding AG	1.05%	148,896
23	MCK	McKesson Corporation	1.03%	80,259
24	REGN	Regeneron Pharmaceuticals, Inc.	1.01%	88,316
25	n/a	USD - Spendable Cash	1.00%	64,556,005

Showing 25 of 168 holdings

Subscribe to see the full list

Activate Now

As of Jan 31, 2026